Tagged with Ichnos

Cyril Konto, President & CEO – Ichnos Sciences
China: EpimAb Looks to 2022 IPO & Global Leadership in Bispecific Antibodies
Ichnos CEO on Glenmark Legacy, Biotech Transformation & CAR-T Complementarity
Alessandro Riva – CEO, Ichnos Sciences
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here